Background
The majority of asthma-related cardiac arrests in the UK occur before admission to hospital.
1 Cardiac arrest in asthma is often a terminal event after a period of hypoxaemia, and is associated with: 2  Severe bronchospasm and mucous plugging  Cardiac arrhythmias caused by hypoxia. (This can also be caused by stimulants including inhaled 2 agonists)  Dynamic hyperinflation -air trapping and breath stacking as a result of 'auto-PEEP' leading to increased intrathoracic pressure, decreased venous return and decreased cardiac output.  Tension pneumothorax (often bilateral).
Early recognition of deterioration and life-threatening symptoms by patients, their families and the emergency services is key to preventing cardiac arrest in this group of patients.
Current Practice
Nebulised salbutamol is the main treatment option available to ambulance crews for the management of moderate, severe and life-threatening asthma. Intramuscular adrenaline 1:1000 is advocated in lifethreatening asthma, especially where anaphylaxis is a possible component.
3 Once the patient is in cardiac arrest crews are generally taught to follow the standard cardiac arrest algorithm, with consideration given to early transportation and management of suspected pneumothorax.
Current practice in some Trusts is to administer nebulised salbutamol through a T-piece adapter to patients in cardiac arrest as a result of asthma. This is advocated as an option in the National Clinical Guidelines (2016), and in a number of Trust-specific clinical guides. 
The Case for Change
Experience from the LAS Advanced Paramedic Practitioner programme suggests that tension pneumothorax may be common in patients where this has been used. 4 Because tension pneumothorax is a recognised complication in fatal / near fatal asthma it is difficult to know whether there is a direct causal link. However, it is felt that in the manner taught, and in inexperienced hands, in-line nebulisation poses a significant risk of generating high intrathoracic pressures.
The practice of adding a nebuliser between the bag-valve-mask and the endotracheal tube adds approximately six litres per minute of flow into the circuit, effectively creating a very high level Positive End Expiratory Pressure (PEEP), worsening trapping and increasing the risk of barotrauma. This is worsened by bagging where the operator may squeezes very hard against the increased resistance caused by the pathology, as well as the increased pressure generated by the flow through the nebuliser.
Given the relative infrequency of cardiac arrest attendance by ambulance clinicians, and the rarity of asthma and bronchospasm as a precipitating cause (by individual clinician), it is possible that concepts such as permissive hypercapnoea will be missed as clinicians default to standard practice.
Other potential risks include:
 The circuit (as taught) is potentially complicated, and as it is used infrequently, skill decay is potentially an issue in being able to set it up.  Multiple connections increases the risk of disconnections and failed ventilation  There is a possibility of equipment being substituted with T-pieces that have one-way valves in them, with potentially fatal results.
